Ipratropium bromide for treatment of bethanechol-induced sialorrhea.
Kunwar
Arun R
AR
Doufekias
Eleni
E
Nihalani
Nikhil
N
Iqbal
Mohammad M
MM
D000280:Administration, Inhalation; D000368:Aged; D018723:Bethanechol / Q000009:adverse effects*; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D018721:Muscarinic Agonists / Q000009:adverse effects*; D012798:Sialorrhea / Q000139:chemically induced / Q000188:drug therapy*; D016055:Urinary Retention / Q000188:drug therapy
D018680:Cholinergic Antagonists; D018721:Muscarinic Agonists; D018723:Bethanechol; D009241:Ipratropium